Literature DB >> 30080178

Composition of pertussis vaccine given to infants determines long-term T cell polarization.

Stanley A Plotkin.   

Abstract

The introduction of a whole-cell vaccine against Bordetella pertussis, the causative agent of whooping cough, dramatically reduced disease incidence. Unfortunately, the whole-cell formulation also induces severe reactions in some infants. Because of this, acellular vaccines have been developed, but they are used exclusively in high-income countries. However, the acellular vaccines do not provide long-term protection, and despite the use of routine boosters, the disease is on the rise. In this issue of the JCI, da Silva Antunes and colleagues demonstrate that the whole-cell vaccines promote long-term polarization toward Th1 and Th17 responses, while the acellular vaccines induce Th2 polarization. Moreover, this polarization is long term, as the response to acellular boosters is dependent on the initial vaccine given in infancy. The authors speculate that Tregs may be induced by initial acellular vaccine administration. The results of this study have important implications for the development of pertussis vaccination strategies that would induce Th1 and Th17 polarization.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30080178      PMCID: PMC6118633          DOI: 10.1172/JCI122726

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Why do pertussis vaccines fail?

Authors:  James D Cherry
Journal:  Pediatrics       Date:  2012-04-23       Impact factor: 7.124

Review 2.  Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis.

Authors:  T Roice Fulton; Varun K Phadke; Walter A Orenstein; Alan R Hinman; Wayne D Johnson; Saad B Omer
Journal:  Clin Infect Dis       Date:  2016-02-07       Impact factor: 9.079

Review 3.  The acellular pertussis vaccine trials: an interpretation.

Authors:  S A Plotkin; M Cadoz
Journal:  Pediatr Infect Dis J       Date:  1997-05       Impact factor: 2.129

4.  Waning immunity to pertussis following 5 doses of DTaP.

Authors:  Sara Y Tartof; Melissa Lewis; Cynthia Kenyon; Karen White; Andrew Osborn; Juventila Liko; Elizabeth Zell; Stacey Martin; Nancy E Messonnier; Thomas A Clark; Tami H Skoff
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

5.  Comparison of 13 acellular pertussis vaccines: adverse reactions.

Authors:  M D Decker; K M Edwards; M C Steinhoff; M B Rennels; M E Pichichero; J A Englund; E L Anderson; M A Deloria; G F Reed
Journal:  Pediatrics       Date:  1995-09       Impact factor: 7.124

6.  Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.

Authors:  V Dirix; V Verscheure; T Goetghebuer; M Hainaut; A S Debrie; C Locht; F Mascart
Journal:  Vaccine       Date:  2009-08-07       Impact factor: 3.641

7.  Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.

Authors:  Jeroen Geurtsen; H Alexander Banus; Eric R Gremmer; Henke Ferguson; Liset J J de la Fonteyne-Blankestijn; Jolanda P Vermeulen; Jan A M A Dormans; Jan Tommassen; Peter van der Ley; Frits R Mooi; Rob J Vandebriel
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

8.  Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model.

Authors:  K H Mills; A Barnard; J Watkins; K Redhead
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

Review 10.  Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.

Authors:  F R Mooi; N A T Van Der Maas; H E De Melker
Journal:  Epidemiol Infect       Date:  2013-02-13       Impact factor: 4.434

View more
  2 in total

1.  Pertussis (Whooping Cough).

Authors:  Michael D Decker; Kathryn M Edwards
Journal:  J Infect Dis       Date:  2021-09-30       Impact factor: 5.226

Review 2.  Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines.

Authors:  Anja Saso; Beate Kampmann; Sophie Roetynck
Journal:  Vaccines (Basel)       Date:  2021-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.